Literature DB >> 9052810

Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis.

C J Showalter1, A G Engel.   

Abstract

Immunocytochemical analysis of muscle specimens from 5 patients with acute quadriplegic myopathy indictes that depletion of either fast or slow myosin occurs in this disorder. The initial lesion consists of focal myosin loss in nonatrophic fibers. Other structural proteins (actin, titin, nebulin) are spared or affected only at an advanced stage of the disease. Attempts at regeneration, evidenced by expression of fetal myosin and desmin, occur in some fibers. Calpain expression is markedly enhanced in the affected fibers, implicating an altered calcium homeostasis in the evolution of the pathologic process. By contrast, cathepsin B and ubiquitin expressions are only minimally affected. The history of 1 of our patients indicates that severe systemic illness in and of itself can cause acute quadriplegic myopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052810     DOI: 10.1002/(SICI)1097-4598(199703)20:3<316::AID-MUS8>3.0.CO;2-E

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  22 in total

Review 1.  Persistent systemic inflammation in chronic critical illness.

Authors:  Christopher E Cox
Journal:  Respir Care       Date:  2012-06       Impact factor: 2.258

Review 2.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

Review 3.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

Review 4.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 5.  [Intensive care unit acquired weakness. Pathogenesis, treatment, rehabilitation and outcome].

Authors:  M Ponfick; K Bösl; J Lüdemann-Podubecka; G Neumann; M Pohl; D A Nowak; H-J Gdynia
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

6.  Distinct muscle apoptotic pathways are activated in muscles with different fiber types in a rat model of critical illness myopathy.

Authors:  Benjamin T Barnes; Amy L Confides; Mark M Rich; Esther E Dupont-Versteegden
Journal:  J Muscle Res Cell Motil       Date:  2015-03-05       Impact factor: 2.698

7.  Risk factors for critical illness polyneuromyopathy.

Authors:  J Bednarík; P Vondracek; L Dusek; E Moravcova; I Cundrle
Journal:  J Neurol       Date:  2005-03-30       Impact factor: 4.849

8.  Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation.

Authors:  Gerald S Supinski; Alexander P Alimov; Lin Wang; Xiao-Hong Song; Leigh A Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-02       Impact factor: 5.464

9.  Muscle-specific calpastatin overexpression prevents diaphragm weakness in cecal ligation puncture-induced sepsis.

Authors:  Gerald S Supinski; Lin Wang; Xiao-Hong Song; Jennifer S Moylan; Leigh Ann Callahan
Journal:  J Appl Physiol (1985)       Date:  2014-08-28

Review 10.  Critical illness myopathy and polyneuropathy.

Authors:  Shawn J Bird; Mark M Rich
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.